Skip to main content

UBS Group AG

Position in INAB — In8bio, Inc.

CIK 1610520 ZURICH, V8

Position in INAB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1
-$708 QoQ
Shares Held
1
-99.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 21 holders
Holding Since
Sep 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. INAB ranks #552 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in INAB

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1 1
2026-03-31 $709 480
2025-12-31 $1,817 777
2025-09-30 $32 15
2025-06-30 $1,001 479
2025-03-31 $2,045 12,327
2024-12-31 $15,125 58,853
2024-09-30 $7,092 26,270
2023-12-31 $6,216 4,505
2023-09-30 $5,166 4,968
2023-03-31 $4,072 3,133
2022-12-31 $7,992 3,460
2022-09-30 $17,622 8,724
2022-06-30 $9,085 4,020
2022-03-31 $12,790 3,841
2021-12-31 $7,612 1,734
2021-09-30 $23,529 3,435